[1]
Matsukawa, J. et al. 2025. Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study. Journal of Clinical Gynecology & Obstetrics. (Mar. 2025). DOI:https://doi.org/10.14740/jcgo1506.